* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.
Scientists are learning more about how people respond to SARS-CoV-2, the new coronavirus responsible for the ongoing COVID-19 pandemic. Findings from a recent study suggest that prior exposure to “common cold” coronaviruses may generate the production of SARS-CoV-2 specific T cells.
SARS-CoV-2 belongs to the Coronaviridae family of RNA viruses. There are four coronaviruses known to circulate among the world’s population and transmit the “common cold.”
A healthy person’s response to a viral infection involves a coordinated effort between the innate and adaptive immune systems. Whereas the innate immune system — the first line of defense — involves barrier functions, such as those provided by the skin, the adaptive immune system includes distinct cell types that work together to neutralize the virus. T cells kill virus-infected cells and present viral fragments to B cells, which in turn produce antibodies against the virus. Some T cells, known as memory T cells, are long-lived and persist in the body to defend against future attacks by the same virus or related viruses.
Previous research on other viral infections has demonstrated that cross-reactive T cells circulating in a person’s blood may protect them from developing severe disease. The current study investigated the T cell response to the SARS-CoV-2 virus and explored the features of cross-reactive immunity.
The authors of the study examined blood collected from healthy people prior to the emergence of the SARS-CoV-2 virus. They detected CD4+ T cells in the blood of approximately half of the people unexposed to the SARS-CoV-2 virus. The authors speculate that these observations indicate the existence of cross-reactive immunity between SARS-CoV-2 and the coronaviruses that cause the “common cold.” They submit that this cross-reactivity may be a hopeful sign. However, it may also complicate COVID-19 vaccine trials if some subjects have pre-existing immunity.
These findings suggest that prior exposure to a related coronavirus stimulates the production of SARS-CoV-2 reactive T cells that persist in the body. Whether these T cells help an individual clear COVID-19 remains to be seen.
The science digest is a special email we send out just twice per month to members of our premium community. It covers in-depth science on familiar FoundMyFitness related topics.
If you're interested in trying out a few issues for free, enter your email below or click here to learn more about the benefits of premium membership here.